You are here: Home » International » News » Companies
Business Standard

Malaysia's IHH Healthcare dismisses report it's close to buying Fortis

The Malaysian healthcare major runs chain of hospitals in Asia, and Central and Eastern Europe

Press Trust of India  |  New Delhi 

Fortis Hospital
Fortis Hospital

Malaysia's healthcare services provider IHH Healthcare Berhad today said it is not close to "concluding any negotiations" to buy controlling stake in

The company, however, maintained that it is constantly evaluating growth opportunities in select geographies in Asia including India, which is its fourth "home market".


According to media reports, the company, which was earlier speculated to have been in advanced talks with the Singh brothers, Malvinder and Shivinder, to acquire controlling stake in and SRL Diagnostics, has pulled out of the talks.

"IHH is not, nor is it close to, concluding any negotiations or due diligence or transactions in India at this point in time," IHH Healthcare Berhad said in a filing to Bursa Malaysia.

Fortis Healthcare, which has already got shareholders nod to raise up to Rs 5,000 crore, has maintained that it was still evaluating the best possible way to raise the funds and no firm decision has been approved by the board till date.

"The board of the company had approved the enabling fund raising options up to Rs 5,000 crore including but not limited to qualified institutional placement, foreign currency convertible bonds or any other method...," had said in a BSE filing earlier this month.

The Singh brothers have been looking to raise fund to repay debt in RHC Holding.

In Martch this year, IHH had sold over 6 per cent stake in India's healthcare major for about Rs 1,070 crore through an open market transaction.

The Malaysian healthcare major runs chain of hospitals under Mount Elizabeth, Gleneagles, Pantai, Parkway and Acibadem brands in Asia and Central and Eastern Europe.

First Published: Thu, June 22 2017. 21:11 IST
RECOMMENDED FOR YOU